These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 19198789)
41. Antineutrophil cytoplasmic antibody-associated vasculitides. Puéchal X Joint Bone Spine; 2007 Oct; 74(5):427-35. PubMed ID: 17574472 [TBL] [Abstract][Full Text] [Related]
42. European League Against Rheumatism/European Vasculitis Study Group recommendations for the management of vasculitis. Villa-Forte A; ; Curr Opin Rheumatol; 2010 Jan; 22(1):49-53. PubMed ID: 19823089 [TBL] [Abstract][Full Text] [Related]
43. [Treatment of Takayasu arteritis]. Hellmich B Z Rheumatol; 2020 Aug; 79(6):532-544. PubMed ID: 32430564 [TBL] [Abstract][Full Text] [Related]
44. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature. Kötter I; Henes JC; Wagner AD; Loock J; Gross WL Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655 [TBL] [Abstract][Full Text] [Related]
45. Guidelines for management of rheumatic diseases in developing countries from basics to real-world situation: relevance, need, and processes for development. Misra DP; Sharma A; Agarwal V Rheumatol Int; 2018 Apr; 38(4):549-556. PubMed ID: 29445869 [TBL] [Abstract][Full Text] [Related]
46. Diagnostic and treatment standards in idiopathic pulmonary fibrosis in the era of antifibrotic drugs in Poland: A real-world practice survey. Majewski S; Lewandowska K; Martusewicz-Boros MM; Piotrowski WJ Adv Respir Med; 2019; 87(6):221-230. PubMed ID: 31970724 [TBL] [Abstract][Full Text] [Related]
47. ANCA-associated vasculitides: Recommendations of the French Vasculitis Study Group on the use of immunosuppressants and biotherapies for remission induction and maintenance. Terrier B; Charles P; Aumaître O; Belot A; Bonnotte B; Crabol Y; Durel CA; Ebbo M; Jourde-Chiche N; Lega JC; Puéchal X; Pugnet G; Quemeneur T; Ribi C; Samson M; Vandergheynst F; Guillevin L; Presse Med; 2020 Oct; 49(3):104031. PubMed ID: 32645418 [TBL] [Abstract][Full Text] [Related]
48. Unmet Needs in the Pathogenesis and Treatment of Vasculitides. Muratore F; Pazzola G; Soriano A; Pipitone N; Croci S; Bonacini M; Boiardi L; Salvarani C Clin Rev Allergy Immunol; 2018 Apr; 54(2):244-260. PubMed ID: 28895041 [TBL] [Abstract][Full Text] [Related]
49. Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Mukhtyar C; Flossmann O; Hellmich B; Bacon P; Cid M; Cohen-Tervaert JW; Gross WL; Guillevin L; Jayne D; Mahr A; Merkel PA; Raspe H; Scott D; Witter J; Yazici H; Luqmani RA; Ann Rheum Dis; 2008 Jul; 67(7):1004-10. PubMed ID: 17911225 [TBL] [Abstract][Full Text] [Related]